cicloprolol has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frais, MA; Reynolds, G; Sharma, SK; Silke, B; Taylor, SH; Verma, SP | 1 |
| Baig, W; Frais, MA; Jackson, NC; Reynolds, G; Sharma, SK; Silke, B; Taylor, SH; Verma, SP | 1 |
1 trial(s) available for cicloprolol and Coronary Disease
| Article | Year |
|---|---|
Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Exercise; Hemodynamics; Humans; Injections, Intravenous; Middle Aged; Propanolamines; Random Allocation | 1989 |
1 other study(ies) available for cicloprolol and Coronary Disease
| Article | Year |
|---|---|
Haemodynamic dose-response actions of cicloprolol in left ventricular dysfunction due to ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Cardiac Output; Coronary Disease; Dose-Response Relationship, Drug; Exercise Test; Hemodynamics; Humans; Middle Aged; Myocardial Contraction; Myocardial Infarction; Propanolamines | 1987 |